foxo4 dri senolytic or senomorphic The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI FOXO4-DRI regulates endothelial cell senescence
FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Targeting Senescence: A Review of Senolytics and Senomorphics in Anti Aging Interventions Cleara Biotech senolytic candidate FOXO4 DRI Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data
Pay in 4 interest-free payments of $5.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





